Evaluating lung tumor elasticity using ultrasound
Official title: Application of Transthoracic Shear-wave Ultrasound Elastography in the Diagnosis of Pulmonary Lesions
Run by National Taiwan University Hospital · NCT03376425 · Data updated 2026-11-12
This study is testing if a special ultrasound can help doctors tell the difference between harmless and harmful lung tumors by looking at how stretchy they are.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 100 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | December 8, 2017 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | November 18, 2024 |
| Trial ID | NCT03376425 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 20 and older with radiographic evidence of pulmonary tumors.
✕Probably not a fit
Patients under 20 years old or those unable to hold their breath for 5 seconds may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess tissue elasticity in various types of pulmonary lesions using transthoracic shear-wave ultrasound elastography. It focuses on validating the technique's ability to differentiate between benign and malignant lung tumors based on their elasticity properties. The study will analyze data from a retrospective cohort of patients with radiographic evidence of pulmonary tumors collected between January 2016 and December 2017. The findings could enhance diagnostic accuracy for lung lesions.
Why it matters
Potential benefit: If successful, this study could improve the ability to accurately differentiate between benign and malignant lung tumors, leading to better patient management.
How similar studies have gone: Other studies have shown promise in using elastography for similar applications, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Inclusion criteria: (1) Retrospective cohort from Jan 2016 to Dec 2017 (2) Patients with radiographic evidence of pulmonary tumors 2. Exclusion criteria: (1) age \< 20 y/o (2) patients who can't hold their breath for 5 seconds
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Yao-Wen Kuo, MD — National Taiwan University Hospital
- Study coordinator: Yao-Wen Kuo
- Email: kyw@ntu.edu.tw
- Phone: 0972-651-821
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using deep learning to assess liver diseases with ultrasound data
This study is testing if a new deep learning method using ultrasound data can better identify liver diseases in patients compared to traditional methods.
-
AI-assisted home-based mood diary for kids with ADHD
A home-based program uses an AI-assisted diary that turns daily mood entries into comic strips to see if it helps kids with ADHD improve emotion regulation.
-
Probiotic supplement BRCAS-C3 and its effect on androgen levels
This pilot study tests whether taking Bacillus coagulans BRCAS-C3 daily for 24 weeks can safely lower or alter androgen levels in healthy adults.
-
Biomarkers that predict medication-related side effects in children with ADHD
This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.
-
Daily-life Virtual Reality Training to Support Thinking and Daily Tasks in adults 50 and older
A touchscreen-based daily-life VR program is being tested to see if it helps people 50+ improve daily activities and thinking skills, especially for those at risk of dementia.
-
Pompe disease long-term monitoring with avalglucosidase alfa
This is an observational program to see how people with Pompe disease who started avalglucosidase alfa fare over time, including biomarkers, muscle and breathing function, and safety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.